To include your compound in the COVID-19 Resource Center, submit it here.

Coviracil emtricitabine: Phase III data; under review

VIRS said interim data from an international Phase III trial (study FTC-301) showed 81% of patients given its Coviracil had

Read the full 201 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE